Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Classement en actions #31257
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Prix de l'action
$0.39
Dernière synchronisation: 2026-08-18
Capitalisation boursière
$13.79M
Changement (1 jour)
-13.53%
Changement (1 an)
-66.38%
Pays
IL
Échange NeuroSense Therapeutics Ltd. (NRSN)

Catégorie

Historique des divisions d’actions pour NeuroSense Therapeutics Ltd. (NRSN)
L’action NeuroSense Therapeutics Ltd. (symbole : NRSN) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 19, 2026.
Une action NRSN achetée avant le Aug 19, 2026 équivaudrait aujourd’hui à 0 actions NRSN.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE